↓ Skip to main content

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

Overview of attention for article published in Journal of Translational Medicine, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
Published in
Journal of Translational Medicine, January 2015
DOI 10.1186/1479-5876-13-s1-o5
Pubmed ID
Authors

Reinhard Dummer, Adil Daud, Igor Puzanov, Omid Hamid, Dirk Schadendorf, Caroline Robert, Jacob Schachter, Anna Pavlick, Rene Gonzalez, F Stephen Hodi, Lee D. Cranmer, Christian Blank, Steven J. O’Day, Paolo A. Ascierto, April K. S. Salama, Nicole Xiaoyun Li, Wei Zhou, Joy Lis, Scot Ebbinghaus, Peter S. Kang, Antoni Ribas

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 22%
Student > Bachelor 6 12%
Student > Postgraduate 5 10%
Student > Master 5 10%
Other 4 8%
Other 12 24%
Unknown 6 12%
Readers by discipline Count As %
Medicine and Dentistry 15 31%
Biochemistry, Genetics and Molecular Biology 6 12%
Agricultural and Biological Sciences 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Immunology and Microbiology 3 6%
Other 5 10%
Unknown 11 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2015.
All research outputs
#4,369,297
of 25,371,288 outputs
Outputs from Journal of Translational Medicine
#783
of 4,634 outputs
Outputs of similar age
#59,882
of 377,403 outputs
Outputs of similar age from Journal of Translational Medicine
#21
of 123 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,634 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 377,403 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.